BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33116514)

  • 21. Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system.
    Gagliardi A; Paolino D; Iannone M; Palma E; Fresta M; Cosco D
    Int J Nanomedicine; 2018; 13():601-614. PubMed ID: 29430179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies of stabilization of zein nanoparticles containing doxorubicin hydrochloride.
    Ambrosio N; Gagliardi A; Voci S; Salvatici MC; Fresta M; Cosco D
    Int J Biol Macromol; 2023 Jul; 243():125222. PubMed ID: 37285879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.
    Birukawa NK; Murase K; Sato Y; Kosaka A; Yoneda A; Nishita H; Fujita R; Nishimura M; Ninomiya T; Kajiwara K; Miyazaki M; Nakashima Y; Ota S; Murakami Y; Tanaka Y; Minomi K; Tamura Y; Niitsu Y
    J Biol Chem; 2014 Jul; 289(29):20209-21. PubMed ID: 24867951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core-Shell Biopolymer Nanoparticles for Co-Delivery of Curcumin and Piperine: Sequential Electrostatic Deposition of Hyaluronic Acid and Chitosan Shells on the Zein Core.
    Chen S; McClements DJ; Jian L; Han Y; Dai L; Mao L; Gao Y
    ACS Appl Mater Interfaces; 2019 Oct; 11(41):38103-38115. PubMed ID: 31509373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid.
    Telange DR; Jain SP; Pethe AM; Kharkar PS; Rarokar NR
    Int J Biol Macromol; 2021 Feb; 171():288-307. PubMed ID: 33418046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
    Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
    Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gallic acid-PAMAM and gallic acid-phospholipid conjugates, physicochemical characterization and in vivo evaluation.
    Abdou EM; Masoud MM
    Pharm Dev Technol; 2018 Jan; 23(1):55-66. PubMed ID: 28627282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
    Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
    Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite/Zein nano-drug delivery system for doxorubicin hydrochloride.
    Zha L; Wang B; Qian J; Fletcher B; Zhang C; Dong Q; Chen W; Hong L
    J Pharm Pharmacol; 2020 Apr; 72(4):496-506. PubMed ID: 31975457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 31. Design of Zein Conjugation and Surface Modification for Targeting Drug Delivery.
    Tran PH; Tran TT
    Curr Drug Targets; 2020; 21(4):406-415. PubMed ID: 31518220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCLAREIN (SCLAREol contained in zeIN) nanoparticles: Development and characterization of an innovative natural nanoformulation.
    Gagliardi A; Voci S; Bonacci S; Iriti G; Procopio A; Fresta M; Cosco D
    Int J Biol Macromol; 2021 Dec; 193(Pt A):713-720. PubMed ID: 34717977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans.
    Lucio D; Martínez-Ohárriz MC; Jaras G; Aranaz P; González-Navarro CJ; Radulescu A; Irache JM
    Eur J Pharm Biopharm; 2017 Dec; 121():104-112. PubMed ID: 28986295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells.
    Xia S; Liu Z; Cai J; Ren H; Li Q; Zhang H; Yue J; Zhou Q; Zhou T; Wang L; Liu X; Zhou X
    J Control Release; 2023 Mar; 355():54-67. PubMed ID: 36693527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication, characterization and properties of DHA-loaded nanoparticles based on zein and PLGA.
    Liu E; Su Z; Yang C; Ji Y; Liu B; Meng X
    Food Chem; 2021 Oct; 360():129957. PubMed ID: 33989879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of zein incorporation on hydrophobic drug-loading capacity and colloidal stability of phospholipid nanoparticles.
    Hong SS; Thapa RK; Kim JH; Kim SY; Kim JO; Kim JK; Choi HG; Lim SJ
    Colloids Surf B Biointerfaces; 2018 Nov; 171():514-521. PubMed ID: 30096472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis.
    Younis MA; Sato Y; Elewa YHA; Kon Y; Harashima H
    J Control Release; 2023 Jan; 353():685-698. PubMed ID: 36521688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin-Based Silibinin Nanocrystals Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy.
    Luo S; Yang Y; Zhao T; Zhang R; Fang C; Li Y; Zhang Z; Gong T
    ACS Appl Mater Interfaces; 2023 Feb; 15(6):7747-7758. PubMed ID: 36719351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication and Characterization of Lutein-Loaded Nanoparticles Based on Zein and Sophorolipid: Enhancement of Water Solubility, Stability, and Bioaccessibility.
    Yuan Y; Li H; Liu C; Zhang S; Xu Y; Wang D
    J Agric Food Chem; 2019 Oct; 67(43):11977-11985. PubMed ID: 31589424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence.
    El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
    J Control Release; 2018 Aug; 283():32-44. PubMed ID: 29792888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.